Fertility clinics provide assisted reproductive technology (ART) services including IVF, IUI, egg freezing, genetic testing, and donor programs to individuals and couples experiencing infertility. The industry sits at the intersection of elective healthcare and medically necessary treatment, commanding premium self-pay pricing while increasingly benefiting from expanded insurance mandates. Private equity consolidation has accelerated significantly since 2015, creating well-capitalized national platforms competing against independent physician-owned clinics.
Who buys these: Private equity firms specializing in healthcare, large regional fertility networks, strategic acquirers such as US Fertility or CCRM, and high-net-worth physicians seeking platform investments
5–9×
Typical EBITDA multiple
$2M–$5M
Revenue range
Growing
Market trend
Browse Fertility Clinic Businesses for Sale →
Search live acquisition targets near you — pre-filtered to Fertility Clinic
Minimum $1.5M EBITDA, established IVF laboratory with SART membership, at least one board-certified reproductive endocrinologist under contract, strong patient review scores, diversified payer mix with some self-pay, and clean regulatory history with no CDC adverse reports
Get Deal Flow In Your Inbox
New Fertility Clinic acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Fertility Clinic acquisition
What buyers typically pay for Fertility Clinic businesses
5×
Low Multiple
7×
Mid Multiple
9×
High Multiple
Fertility Clinic businesses in the $2M–$5M revenue range trade at 5–9× EBITDA in the lower middle market. Multiple variance is driven by recurring revenue percentage, owner dependency, client concentration, and growth trajectory. Growing market conditions support multiples at or above the midpoint.
Full valuation guide for Fertility ClinicSBA eligibility for Fertility Clinic acquisitions varies by deal structure and business type. Many deals use conventional loans, seller notes, or private equity. Common structures include: Asset purchase with physician employment agreement rolled into a Professional Services Agreement through a Management Services Organization (MSO) structure; Equity recapitalization where founding physician retains 20–40% equity stake and receives earnout tied to patient volume and EBITDA growth over 3–5 years.
Typical acquirer profile for this segment
Private equity-backed fertility network platforms such as US Fertility, CCRM, or Inception Fertility seeking geographic expansion; regional health systems adding reproductive medicine service lines; or entrepreneurial physicians building a multi-site fertility group practice
What to investigate before buying a Fertility Clinic business
Seller Intelligence
Who sells Fertility Clinic businesses?
Founder reproductive endocrinologists approaching retirement age (55–70), physician partners seeking liquidity events, and small group practices unable to compete with larger fertility networks without capital investment
Typical exit timeline: 18–24 months
Fertility Clinic businesses in the $2M–$5M revenue range typically sell for 5–9× EBITDA. Minimum $1.5M EBITDA, established IVF laboratory with SART membership, at least one board-certified reproductive endocrinologist under contract, strong patient review scores, diversified payer mix with some self-pay, and clean regulatory history with no CDC adverse reports
Fertility Clinic businesses typically trade at 5–9× EBITDA in the lower middle market. The market is moderately fragmented with growing demand, which supports premium multiples.
SBA eligibility for Fertility Clinic businesses depends on the specific deal. The most common structures are: Asset purchase with physician employment agreement rolled into a Professional Services Agreement through a Management Services Organization (MSO) structure; Equity recapitalization where founding physician retains 20–40% equity stake and receives earnout tied to patient volume and EBITDA growth over 3–5 years.
Key due diligence areas include: Physician employment agreements, non-competes, and transition risk if key RE departs post-close; CDC ART success rate reports, SART data, and laboratory accreditation status under CLIA; Payer mix analysis including self-pay rates, insurance reimbursement contracts, and fertility benefit employer agreements; IVF laboratory equipment condition, age, maintenance records, and estimated capital replacement costs; Patient data privacy compliance under HIPAA, state genetic information laws, and embryo disposition consent protocols.
More Fertility Clinic Guides
Fertility Clinic for Sale: What Buyers Need to Know
Fertility clinics are high-complexity, high-value healthcare acquisitions. Here's what buyers, physicians, and investors need to know about deal structure, valuation, and regulatory requirements.
How to Buy an Occupational Therapy Clinic
OT clinics trade at 4–6x EBITDA with strong insurance revenue and aging-population tailwinds. Here's how to evaluate, finance, and close an occupational therapy acquisition.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers